Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick C Nucifora

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Schizophrenia Bulletin Open|June 10, 2025
Clozapine as a Long-Term Therapeutic Choice: Longitudinal Analysis of Schizophrenia Symptoms in a Naturalistic SettingRachel K Scheinberg, Zhirui Fu, Laura Scott, et al.
Schizophrenia Research|January 1, 2017
Analysis of differential gene expression mediated by clozapine in human postmortem brainsBrian J Lee, Luigi Marchionni, Carrie E Andrews, et al.
Journal of Psychiatric Research|July 8, 2026
Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of lifeBrian J Lee, Brendan Driscoll, Rachel Scheinberg, et al.
Translational Psychiatry|March 11, 2022
Sex-specific involvement of the Notch-JAG pathway in social recognitionHanna Jaaro-Peled, Melissa A Landek-Salgado, Nicola G Cascella, et al.
Molecular Psychiatry|April 4, 2025
Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patientsLeslie G Nucifora, Koko Ishizuka, Nagat El Demerdash, et al.
The American Journal of Psychiatry|May 7, 2019
Increased Protein Insolubility in Brains From a Subset of Patients With SchizophreniaLeslie G Nucifora, Matthew L MacDonald, Brian J Lee, et al.
Molecular Psychiatry|October 13, 2021
A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistanceKun Yang, Luisa Longo, Zui Narita, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Science Advances|June 17, 2026
NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognitionKateryna Murlanova, Ksenia Novototskaya-Vlasova, Shovgi Huseynov, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Schizophrenia Bulletin Open|June 10, 2025
Clozapine as a Long-Term Therapeutic Choice: Longitudinal Analysis of Schizophrenia Symptoms in a Naturalistic SettingRachel K Scheinberg, Zhirui Fu, Laura Scott, et al.
Schizophrenia Research|January 1, 2017
Analysis of differential gene expression mediated by clozapine in human postmortem brainsBrian J Lee, Luigi Marchionni, Carrie E Andrews, et al.
Journal of Psychiatric Research|July 8, 2026
Clozapine facilitates sustained improvement in psychotic symptoms with a subsequent cascade of effects on functioning and quality of lifeBrian J Lee, Brendan Driscoll, Rachel Scheinberg, et al.
Translational Psychiatry|March 11, 2022
Sex-specific involvement of the Notch-JAG pathway in social recognitionHanna Jaaro-Peled, Melissa A Landek-Salgado, Nicola G Cascella, et al.
Molecular Psychiatry|April 4, 2025
Protein aggregation identified in olfactory neuronal cells is associated with cognitive impairments in a subset of living schizophrenia patientsLeslie G Nucifora, Koko Ishizuka, Nagat El Demerdash, et al.
The American Journal of Psychiatry|May 7, 2019
Increased Protein Insolubility in Brains From a Subset of Patients With SchizophreniaLeslie G Nucifora, Matthew L MacDonald, Brian J Lee, et al.
Molecular Psychiatry|October 13, 2021
A multimodal study of a first episode psychosis cohort: potential markers of antipsychotic treatment resistanceKun Yang, Luisa Longo, Zui Narita, et al.
Nature Communications|June 9, 2016
Ubiqutination via K27 and K29 chains signals aggregation and neuronal protection of LRRK2 by WSB1Frederick C Nucifora, Leslie G Nucifora, Chee-Hoe Ng, et al.
Schizophrenia Bulletin|June 15, 2025
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine UtilizationDeanna L Kelly, Jared Hunt, Gopal Vyas, et al.
Science Advances|June 17, 2026
NPAS3-regulated astrocyte mitochondrial bioenergetics is required for cognitionKateryna Murlanova, Ksenia Novototskaya-Vlasova, Shovgi Huseynov, et al.
Pageof 4